Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistGlenn Burkett Naples Corporation marketed multiple products including colloidal silver solutions, dietary supplements, and other formulations as unapproved new drugs by making disease treatment and prevention claims on their websites and social media channels. The company violated the Federal Food, Drug, and Cosmetic Act by selling products intended to cure, mitigate, treat, or prevent diseases in humans and animals without FDA approval, including specific claims that colloidal silver products could treat COVID-19. The products were also found to be misbranded, as they lacked required FDA approval despite being marketed with therapeutic health claims that classified them as drugs rather than dietary supplements or cosmetics.